Balancing access to opioid substitution treatment (OST) with preventing the diversion of opioid substitution medications in Europe: challenges and implications 10. Únor 2021, rubrika EUDA news
14. Leden 2026 Horizon Europe 2026–2027: new EU funding opportunities for drug-related research The European Commission has published the Horizon Europe Work Programmes for 2026–2027, confirming EUR 14 billion in EU...
